佰仁医疗(688198.SH)前三季度净利润9269.69万元，同比增长57.93%

Core Viewpoint - Baijun Medical (688198.SH) reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong business performance and growth potential [1] Financial Performance - The total operating revenue for the first three quarters reached 382 million yuan, representing a year-on-year growth of 30.58% [1] - The net profit attributable to shareholders was 92.7 million yuan, showing a year-on-year increase of 57.93% [1] - The basic earnings per share stood at 0.67 yuan [1]